Loading...
You have changed your country from
to
. Please be aware that this will change the currency in the purchasing process.
Related products
- Primary antibodies
- Secondary antibodies
Reassurance, Refunds & Replacements
If your product does not perform as described on this datasheet, we will refund or replace your product...
Read our guarantee »Overview
Product name
Anti-MEK2 antibody
See all MEK2 products (12) ...
Description
Rabbit polyclonal to MEK2
Tested applications
WB, ELISA, IHC-P, IP, ICC/IFmore details
Cross reactivity
Reacts with
Mouse, Human
Immunogen
Synthetic non-phosphopeptide derived from human MEK2 around the phosphorylation site of Threonine 394.
Positive control
WB: extracts from ovary canner cells. IHC-P: breast carcinoma.
Properties
Form
Liquid
Storage instructions
Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze / thaw cycles.
Storage buffer
Preservative: 0.02% Sodium Azide.
Constituents: 50% Glycerol, PBS (without Mg2+ and Ca2+), 150mM Sodium chloride, pH 7.4.
Concentration
Concentration information loading...
Purity
Immunogen affinity purified
Purification notes
This antibody was purified from rabbit antiserum by affinity chromatography using epitope specific peptide.
Clonality
Polyclonal
Isotype
IgG
Applications
Show applications key
Our Abpromise guarantee covers the use of ab28834 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
WB: 1/500 - 1/1000. Detects a band of approximately 46 kDa (predicted molecular weight: 44 kDa).
ELISA
ELISA: 1/10000.ELISA: 1/10000.
IHC-P: 1/50 - 1/100.
IP: Use at an assay dependent dilution.
ICC/IF: Use a concentration of 1 - 5 µg/ml.
Target
Function
Catalyzes the concomitant phosphorylation of a threonine and a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. Activates the ERK1 and ERK2 MAP kinases.
Involvement in disease
Defects in MAP2K2 are a cause of cardiofaciocutaneous syndrome (CFC syndrome) [MIM:115150]; also known as cardio-facio-cutaneous syndrome. CFC syndrome is characterized by a distinctive facial appearance, heart defects and mental retardation. Heart defects include pulmonic stenosis, atrial septal defects and hypertrophic cardiomyopathy. Some affected individuals present with ectodermal abnormalities such as sparse, friable hair, hyperkeratotic skin lesions and a generalized ichthyosis-like condition. Typical facial features are similar to Noonan syndrome. They include high forehead with bitemporal constriction, hypoplastic supraorbital ridges, downslanting palpebral fissures, a depressed nasal bridge, and posteriorly angulated ears with prominent helices. The inheritance of CFC syndrome is autosomal dominant.
Sequence similarities
Belongs to the protein kinase superfamily. STE Ser/Thr protein kinase family. MAP kinase kinase subfamily.
Contains 1 protein kinase domain.
Post-translational
modifications
MAPKK is itself dependent on Ser/Thr phosphorylation for activity catalyzed by MAP kinase kinase kinases (RAF or MEKK1).
Acetylation of Ser-222 and Ser-226 by Yersinia yopJ prevents phosphorylation and activation, thus blocking the MAPK signaling pathway.
Target information above from: UniProt accessionP36507
The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).
Alternative names
- Cardiofaciocutaneous syndrome antibody
- CFC syndrome antibody
- Dual specificity mitogen activated protein kinase kinase 2 antibody
see all
Database links
- Entrez Gene: 5605 Human
- Entrez Gene: 26396 Mouse
- Omim: 601263 Human
- SwissProt: P36507 Human
- SwissProt: Q63932 Mouse
- Unigene: 465627 Human
- Unigene: 275436 Mouse
Anti-MEK2 antibody images:
Immunohistochemistry (Paraffin-embedded sections) - MEK2 antibody (ab28834)
Ab28834 staining MEK2 in paraffin embedded human breast carcinoma tissue by Immunohistochemistry.
Left image: untreated.
Right image: preincubated with synthesized peptide.
Western blot - MEK2 antibody (ab28834)
All lanes : Anti-MEK2 antibody (ab28834) at 1/500 dilution (extracts from ovary canner cells (5-30ug).)
Lane 1 : Line 1: using MEK2 antibody
Lane 2 : Line 2: the same antibody preincubated with synthesized peptide.
Predicted band size : 44 kDa
Observed band size : 46 kDa (why is the actual band size different from the predicted?)
Immunocytochemistry/ Immunofluorescence-MEK2 antibody(ab28834)
ICC/IF image of ab28834 stained HeLa cells. The cells were 100% methanol fixed (5 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab28834, 1µg/ml) overnight at +4°C. The secondary antibody (green) was Alexa Fluor® 488 goat anti-rabbit IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43µM.
References for Anti-MEK2 antibody (ab28834)
ab28834 has not yet been referenced specifically in any publications.
Publishing research using ab28834? Please let us know so that we can cite the reference in this datasheet
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"